Enlicitide Synthetic Peptide | C135PS
$1,200.00 – $4,800.00
Enlicitide Synthetic Peptide. Enlicitide Synthetic Peptide stable cell line is available for licensing to manufacture the semaglutide biosimilar. The research grade semaglutide biosimilar is for research use only (RUO).
- Details & Specifications
- References
| Catalog No. | C135PS |
|---|---|
| Product Name | Enlicitide Synthetic Peptide |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Source/Host | The enlicitide peptide was synthesized. |
| Applications | ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by enlicitide. |
| Endotoxin | < 1 EU per 1 mg of the peptide by the LAL method. |
| Purity | >98% by HPLC |
| Shipping | The research grade enlicitide synthetic peptide is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | The research grade enlicitide synthetic peptide is for research use only (RUO). |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C135PS: Enlicitide Synthetic Peptide
Background
What is research grade enlicitide decanoate synthetic peptide? Research-grade Enlicitide Decanoate Synthetic Peptide is a synthetic macrocyclic peptide inhibitor targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of low-density lipoprotein receptor (LDLR) metabolism and cholesterol homeostasis. Enlicitide decanoate (MK-0616) is designed to inhibit the interaction between PCSK9 and LDLR, thereby preventing PCSK9-mediated LDL receptor degradation, promoting LDLR recycling, and enhancing cellular uptake of low-density lipoprotein cholesterol (LDL-C). As a novel peptide-based PCSK9 inhibitor, Enlicitide Decanoate features a highly constrained macrocyclic structure that enables high-affinity target binding and improved peptide stability compared with conventional linear peptides. Research-grade Enlicitide Decanoate Synthetic Peptide is widely used as a valuable tool for studying PCSK9 signaling, LDLR regulation, cholesterol metabolism, lipid homeostasis, cardiovascular biology, and next-generation peptide drug discovery. This product is supplied for research use only (RUO) and is not intended for human therapeutic applications.
Syd Labs also provides the following GLP-1 receptor agonist synthetic peptide:
Semaglutide Synthetic Peptide
Retatrutide Synthetic Peptide
Tirzepatide Synthetic Peptide
Enlicitide Synthetic Peptide from: Enlicitide Synthetic Peptide, Research Grade – Syd Labs




